First and foremost at Servier, we specialise in medicinal products. Our primary focus is and always has been researching, developing, fine-tuning, and marketing innovative therapeutics, also known as originator drugs.
For nearly 50 years our medicines have been the fruits of our R&D labour. Over the past decade, we have been forging agreements with other companies in order to access novel treatments. We also manufacture high quality generics through our independent subsidiaries, Biogaran, Egis, and Pharlab.
And because we believe in a comprehensive approach to healthcare, we offer eHealth solutions to oversee the entire course of patient care, from prevention to follow-up. Our medicines and therapeutic solutions are designed to address unmet medical needs in our five areas of excellence: cardiovascular and immune-inflammatory diseases, neuropsychiatric disorders, oncology and diabetes.
Our portfolio of Servier medicines consists of some 20 families of medicines in our fields of expertise.
In order to make high-quality medicines more widely available and accessible, we have a Generics business to complement our core Servier-brand products activity.
We now live in a time where eHealth services represent the most capable way of providing a comprehensive approach to healthcare. They are uniquely positioned to manage and take account of the entire patient pathway, from prevention to follow-up.